Today: 5 April 2026
Subscribe
Browse Category

Stock Market 11 November 2025

Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

Stock Market Today (Nov. 11, 2025): Dow Closes at a Record as AI Shares Stumble; FTSE 100 Hits New High on BoE Cut Bets

The Dow Jones closed at a record 47,927.96 on Nov. 11, 2025, up 1.18%, while the Nasdaq fell 0.25% as Nvidia dropped nearly 3% after SoftBank revealed a $5.8 billion stake sale. The S&P 500 edged higher. In Europe, the FTSE 100 hit a record near 9,900, boosted by Vodafone’s first dividend increase in eight years and rising bets on Bank of England rate cuts.
11 November 2025
········
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia (NVDA) Stock Today: SoftBank Exits $5.8B Stake, CoreWeave Cuts Outlook; NVDA Slips Ahead of Nov. 19 Earnings — November 11, 2025

Nvidia shares fell 2.35% to $194.38 Tuesday after SoftBank disclosed it sold its entire $5.8 billion Nvidia stake. CoreWeave, a key Nvidia customer, cut its 2025 revenue outlook due to a data-center delay. The Dow closed at a record on shutdown optimism, but tech stocks lagged. Nvidia reports Q3 results Nov. 19.
11 November 2025
····
Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts

Tesla Stock Today (11/11/2025): TSLA Slips as China Sales Hit 3‑Year Low, Musk’s Form 4 Lands, and $60/Day Rentals Go Live

Tesla shares slipped 1.3% to around $439.6 midday Tuesday, trading between $432.36 and $442.49. October China sales dropped to 26,006 units, the lowest in three years, while Shanghai exports climbed. Tesla formalized Elon Musk’s 2025 CEO Performance Award in SEC filings covering 423.7 million restricted shares. Program heads for Cybertruck and Model Y announced departures this week.
11 November 2025
··
Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft (MSFT) Stock Today — Nov. 11, 2025: Shares Edge Higher as $10B Portugal AI Hub, Patch Tuesday Fixes and New Enterprise AI Deals Dominate Headlines

Microsoft shares rose 0.6% to $508.68 late Tuesday after the company announced a $10 billion AI data center investment in Sines, Portugal, with partners including NVIDIA. Microsoft also released security updates fixing 63 vulnerabilities, including an actively exploited zero-day. Essity selected Accenture and Microsoft to expand AI adoption. The Dow closed at a record high; Nvidia shares fell.
11 November 2025
··
Apple Stock Today (AAPL) — 11/11/2025: Shares Climb as AI-Spending Discipline Wins Fans; Dividend Arrives This Week

Apple Stock Today (AAPL) — 11/11/2025: Shares Climb as AI-Spending Discipline Wins Fans; Dividend Arrives This Week

Apple shares rose about 2% to $275.25 Tuesday, nearing their 52-week high and pushing market value close to $4 trillion. Investors cited Apple’s lower AI spending compared to rivals, a pending $0.26 dividend payout on November 13, and steady iPhone supply-chain data. The stock traded between $269.80 and $275.91 intraday.
11 November 2025
····
Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna (MRNA) News Today—November 11, 2025: UBS Sees 2026 Upside, Redburn Cuts PT to $36, Bernstein Stays Market Perform After Cost Cuts

Moderna shares rose mid-session Tuesday after UBS cited 2026 upside tied to cost cuts and pipeline progress. Redburn Atlantic lowered its price target to $36, while Bernstein reiterated a $25 target and neutral view, highlighting the need for further expense reductions. The moves follow last week’s Q3 report, which showed a narrower loss and tighter 2025 guidance.
11 November 2025
··
Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer (PFE) Today — Nov. 11, 2025: $10B Metsera Deal Nears Vote, Oncology Game Plan Expands, Shares Rise

Pfizer will acquire Metsera for up to $10 billion, offering $65.60 per share in cash plus contingent value rights, with a shareholder vote set for Nov. 13. Metsera’s board favored Pfizer over Novo Nordisk after FTC antitrust concerns tipped the balance. Pfizer shares rose about 4–5% to $25.50 following the news. The company also announced seven new trials for its PD‑1×VEGF bispecific antibody, including a phase 3 lung cancer study.
11 November 2025
···
Sky on Fire Tonight: Giant ‘Solar Canyon’ Aims 800‑km/s Wind at Earth—Northern Lights Could Ignite 15 U.S. States & Test Global Tech

NOAA Issues G4 ‘Severe’ Geomagnetic Storm Watch for Nov. 12 After X5.1 Solar Flare — Northern Lights Possible as Far South as Indiana Tonight (Nov. 11)

NOAA issued a G4 (Severe) geomagnetic storm watch for Nov. 12 following an X5.1 solar flare early Tuesday. Auroras may reach the northern U.S. and Midwest tonight, with stronger displays possible late Wednesday into Thursday. A solar radiation storm and radio blackout accompanied the flare. Forecasts remain uncertain pending CME arrival and magnetic orientation.
11 November 2025
3I/ATLAS Today (Nov. 11, 2025): Interstellar Comet Reappears with Growing Ion Tail, Morning-Sky Return & Rumor Control

3I/ATLAS Today (Nov. 11, 2025): Interstellar Comet Reappears with Growing Ion Tail, Morning-Sky Return & Rumor Control

Interstellar comet 3I/ATLAS has reappeared in the pre-dawn sky near Virgo, with a lengthened ion tail of about 0.7° and a visible anti-tail, according to new images from Italy. The comet remains intact despite viral claims of an explosion, with NASA confirming no threat to Earth. Closest approach will be about 1.8 AU on Dec. 19. European spacecraft, including JUICE, are scheduled for further observations this month.
11 November 2025
Government Shutdown Panic: Stocks Tumble, Jobs Data Vanish & Millions Brace for Impact

Is the Government Shutdown Over Today? (Nov. 11, 2025) Status, What’s in the Senate Deal, and What Happens Next

The U.S. government remains shut down on Nov. 11, day 42 of the closure, after the Senate passed a bill to reopen it 60–40 last night. The House will not vote until at least tomorrow due to the Veterans Day holiday. Federal services are still disrupted, and the FAA has ordered airlines to cut 6% of domestic flights at major airports today. President Trump has indicated he would sign the bill if it reaches his desk.
11 November 2025
U.S. Space Force Readies ‘Meadowlands’ & Remote Modular Terminal Jammers to Counter China; Space Force Association Pushes Awareness — Nov. 11, 2025

U.S. Space Force Awareness Drive Expands as ‘Meadowlands’ and RMT Jammers Near Fielding — Nov. 11, 2025 Update

The U.S. Space Force will add two new satellite-jamming systems, Meadowlands and the Remote Modular Terminal, to its arsenal, joining the existing Counter Communications System. Meanwhile, the Space Force Association is expanding outreach after new reports show fewer than 10% of Americans know the service exists. The group aims to open chapters in every state and increase education efforts in schools.
11 November 2025
··
Stimulus Check October 2025: Rumors Debunked – What to Know as Shutdown Continues

Are $2,000 Stimulus Checks Coming? Trump’s Tariff ‘Dividend’ Plan, Supreme Court Risks, and What Michiganders Should Know (Nov. 11, 2025)

President Trump reiterated a proposal to send most Americans a $2,000 “tariff dividend” funded by import duties, but Congress would need to approve any payments. Treasury Secretary Scott Bessent suggested benefits might come as tax relief rather than direct checks. Legal and budget obstacles remain, with the Supreme Court reviewing the tariffs’ legality. Michigan officials called the prospect of checks “uncertain and unlikely.”
11 November 2025
Vor Biopharma (VOR) Prices $100M Stock Offering at $10; Shares Slide as Investors Weigh Dilution — Nov. 11, 2025

Vor Biopharma (VOR) Prices $100M Stock Offering at $10; Shares Slide as Investors Weigh Dilution — Nov. 11, 2025

Vor Biopharma priced 10 million new shares at $10 each for $100 million in expected gross proceeds, with underwriters able to buy up to 1.5 million more. Shares fell from $13.03 pre-market to near $10 by mid-morning Tuesday. The offering follows positive Phase 3 IgA nephropathy data from partner RemeGen. The deal is set to close around Nov. 12, 2025, with J.P. Morgan, Jefferies, Citigroup, and TD Cowen as joint bookrunners.
11 November 2025
·
LivePerson (LPSN) Soars After Citron Shout‑Out: Q3 Beat, Guidance Lift, and AI ‘Conversation Simulator’ Fuel Rally — 11/11/2025

LivePerson (LPSN) Soars After Citron Shout‑Out: Q3 Beat, Guidance Lift, and AI ‘Conversation Simulator’ Fuel Rally — 11/11/2025

LivePerson shares surged as much as 43% Tuesday after Citron Research highlighted strong Q3 results and the new Conversation Simulator AI product. The company reported Q3 revenue of $60.2 million (down 19% y/y) and adjusted EBITDA of $4.8 million, both above guidance. Management raised its 2025 outlook for adjusted EBITDA to $7.5–$12.5 million.
11 November 2025
···
Supply@ME Capital (LON: SYME) today — 11 Nov 2025: No new RNS; AGM confirmed for 4 Dec as shares trade around 0.004p

Supply@ME Capital (LON: SYME) today — 11 Nov 2025: No new RNS; AGM confirmed for 4 Dec as shares trade around 0.004p

SYME shares traded near 0.004p by mid-afternoon Tuesday, with volume around 630 million and a quoted spread of 0.003/0.005p. No new company announcements were issued; the last filing was a Notice of AGM on 6 November. The AGM is scheduled for 4 December in London, with proxy votes due by 2 December. Trading resumed on 23 October after the FCA lifted a suspension.
11 November 2025
·
The RealReal (REAL) spikes to new highs after Q3 beat; Wall Street lifts targets to $15–$16 — all the news investors need today (Nov. 11, 2025)

The RealReal (REAL) spikes to new highs after Q3 beat; Wall Street lifts targets to $15–$16 — all the news investors need today (Nov. 11, 2025)

The RealReal shares surged to a 52-week high Tuesday after topping Q3 estimates and raising full-year guidance. Revenue rose 17% to $174 million, with gross merchandise value up 20% to $520 million. Multiple brokers lifted price targets, including BTIG to $15 and Northland to $16. The company now expects 2025 revenue of $687–$690 million.
11 November 2025
··
1 … 1,230 1,231 1,232 1,233 1,234 … 1,371

Stock Market Today

  • Ocugen (OCGN) Shows Strong Momentum Amid Gene Therapy Pipeline Developments
    April 5, 2026, 1:25 AM EDT. Ocugen's (OCGN) stock displayed notable volatility recently with a 30-day return of 11.18% and a 1-year gain of 170.39%, signaling growing momentum. Trading at $1.79, its share price remains well below analysts' average target of $11.57, reflecting optimism about its late-stage gene therapy candidates like OCU400 and OCU410. These therapies target large, unmet medical needs and could drive substantial future revenue. However, reliance on unapproved treatments and ongoing cash burn presents risks, with trial setbacks or funding shortfalls potentially impacting valuations. Investors are encouraged to consider both growth potential and key warning signs before positioning in OCGN shares.
Go toTop